Results of a series of transrectal ultrasound-guided biopsy of the prostate in 6,000 patients. Part I: Pathological anatomy, rectal touch, transrectal echography and PSA;Resultados de una serie de 6000 pacientes con biopsia transrectal ecodirigida de próstata. Parte I: Anatomía patológica, tacto rectal, ecografía transrectal y PSA

Archivos Espanoles de Urologia

Volumn 58, Issue 7, 2005, Pages 611-622

  Rodriguez Patron Rodriguez, Rafael ^a,d   Mayayo Dehesa, Teodoro ^a   Alonso González, Mónica ^b   Burgos Revilla, Francisco Javier ^c   Lennie Zucharino, Alberto ^a  

^a Unidad de Ecografía Urológica   (Spain)

^b Tecnico de Salud   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d NONE   (Spain)

Author keywords

Digital rectal examination; Prostate cancer; Transrectal ultrasound; Transrectal ultrasound guided prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOPSY; BLOOD; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; RECTUM;

BIOPSY; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM;

EID: 33644878280     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. HOHBACH, C.; DHOM, G.: "Pathology of prostate cancer". Scand. J. Urol. Nephrol. Suppl., 55: 37, 1980.
2. STAMEY, T.A.: "Making the most out of six systematic sextant biopsies". Urology, 45: 2, 1995.
3. HOLM, H.H.; GAMMELGAARD, J.: "Ultrasonically-guided precise needle placement in the prostate and seminal vesicles". J. Urol., 125: 385, 1981.
4. FORNAGE, B.D.; TOUCHE, D.H.; DEGLAIRE, M. y cols.: "Real time ultrasound-guided prostatic biopsy using a new transrectal linear-array probe". Radiology, 146: 547, 1983.
5. RIFKIN, M.D.; KURTZ, A.B.; GOLDBERG, B.B.: "Prostate biopsy utilizing transrectal ultrasound guidance: diagnosis of nonpalpable cancers". J. Ultrasound Med., 2: 165, 1983.
6. HODGE, K.K.; McNEAL, J.E.; TERRIS, M.K. y cols.: "Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate". J. Urol., 142: 71, 1989.
7. TERRIS, M.K.; STAMEY, T.A.: "Determination of prostate volume by transrectal ultrasound". J. Urol., 145: 984, 1991.
8. RABBANI, F.; STROUMBAKIS, N.; KAVA, B.R. y cols.: "Incidence and clinical significance of false negative sextant prostate biopsies". J. Urol., 159: 1247, 1998.
9. TERRIS, M.K.: "Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report". Urology, 54: 486, 1999.
10. RODRÍGUEZ, R.; MAYAYO, T.; GALBIS, F. y cols.: "Utilidad clinica de las pruebas diagnósticas disponibles en el carcinoma prostático. Resultados sobre 500 biopsias. Parte II: tacto rectal, PSA y ecografía transrectal". Arch. Esp. Urol., 50: 339, 1997.
11. RODRÍGUEZ, R.; MAYAYO, T.; GALBIS, F. y cols.: "Inflamación prostática crónica: un factor de confusión en el diagnóstico del cáncer prostá tico". Arch. Esp. Urol., 49: 669, 1996.
12. MAYAYO, T.; RODRÍGUEZ-PATRÓN, R.; LENNIE, A. y cols.: "Biopsia transrectal ecodirigida. Análisis de los resultados de una serie de 1900 pacientes". Arch. Esp. Urol., 52: 453, 1999.
13. DJAVAN, B.; MAZAL, P.; ZLOTTA, A. y cols: "Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European prostate cancer detection study". Prostate, 47: 111, 2001.
14. O'DOWD, G.J.; MILLER, M.C.; OROZCO, R. y cols.: "Analysis of repeated biopsy results within 1 year after a noncancer diagnosis". Urology, 55: 553, 2000.
15. OROZCO, R.; O'DOWD, G.J.; KUNNEL, B. y cols.: "Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States". Urology, 51: 186, 1998.
16. CATALONA, W.J.; SMITH, D.S.; RATLIFF, T.L. y cols.: "Measurement of prostate-specific antigen in serum as a screening test for prostate cancer." N. Eng. J. Med., 324: 1156, 1991.
17. ROEHL, K.A.; ANTENOR, J.A.; CATALONA, W.J. y cols.: "Serial biopsy results in prostate cancer screening study". J. Urol., 167: 2435, 2002
18. FRAUSCHER, F.; KLAUSER, A.; VOLGGER, H. y cols.: "Comparison of contrast enhanced color doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection". J. Urol., 167: 1648, 2002.
19. LODDING, P.; AUS, G.; BERGDAHL, S. y cols.: "Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/ml prostate specific antigen". J. Urol., 159: 899, 1998.
20. SMITH, D.S.; CATALONA, W.J.; HERSCHMAN, J.D.: "Longitudinal screening for prostate cancer with prostate-specific antigen". JAMA, 276: 1309, 1996.
21. BASILLOTE, J.B.; ARMENAKAS, N.A.; HOCHBERG, D.A. y cols.: "Influence of prostate volume in the detection of prostate cancer". Urology, 61: 167, 2003.
22. WILLS, M.L.; HAMPER, U.M.; PARTIN, A.W. y cols.: "Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens". Urology, 49: 367, 1997.
23. MOROTE ROBLES, J.; LÓPEZ LÓPEZ, M.; ENCABO DURO, G. y cols.: "Incidencia de las lesiones asociadas en la biopsia prostática y su influencia en la concentratión sérica del antígeno prostático específico". Actas Urol. Esp., 23: 400, 1999.
24. EMILIOZZI, P.; CORSETTI, A.; TASSI, B. y cols.: "Best approach for prostate cancer détection: a prospective study on transperineal versus transrectal six-core prostate biopsy". Urology, 61: 961, 2003.
25. MÍNGUEZ MARTÍNEZ, R.; FERNÁNDEZ BORRELL, A.; GÓMEZ SANCHA, F. y cols.: "Diagnóstico precoz del cancer de próstata en pacientes con sintomatología prostática mediante TR, PSA, ECOTR y DPSA". Actas Urol. Esp., 23: 88, 1999.
26. BROSSNER, C.; MADERSBACHER, S.; KLINGLER, H.C. y cols.: "Comparative study of a double-line versus a fan-shaped technique for obtaining transrectal ultrasound-guided biopsies of the prostate". Eur. Urol., 33: 556, 1998.
27. PRESTI, J.C. Jr.; O'DOWD, G.J.; MILLER, M.C. y cols.: "Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study". J. Urol., 169: 125, 2003.
28. RODRÍGUEZ DUARTE, C.: "Biopsia prostática multi-fragmentaria". Arch. Esp. Urol., 55: 907, 2002.
29. LEVINE, M.A.; ITTMAN, M.; MELAMED, J. y cols.: "Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer". J. Urol., 159: 47, 1998.
30. ESKEW, L.A.; BARE, R.L.; McCULLOUGH, D.L.: "Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate". J. Urol., 157: 199, 1997.
31. RAVERY, V.; GOLDBLATT, L.; ROYER, B. y cols.: "Extensive biopsy protocol improves the detection rate of prostate cancer". J. Urol., 164: 393, 2000.
32. JIMÉNEZ-CRUZ, J.F.; BROSETA, E.: "Diagnostic challenges of prostatic carcinoma". Br. J. Urol., 70: 39, 1992.
33. LEE, F.; GRAY, J.M.; McLEARY, R.D. y cols.: "Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma". Radiology, 158: 91, 1986.
34. LEE, F.; LITTRUP, P.J.; TORP-PEDERSEN, S.T. y cols.: "Prostate cancer: comparison of transrectal US and digital rectal examination for screening". Radiology, 168: 389, 1998.
35. CHODAK, G.W.; WALD, V.; PARMER, E. y cols.: "Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostatic cancer". J. Urol., 135: 951, 1986.
36. MARTÍNEZ HURTADO, J.; CHÉCHILE, G.; VILLAVICENCIO, H.: "Tacto rectal, PSA y ecografía transrectal en el diagnóstico del cáncer prostático". Arch. Esp. Urol., 48: 247, 1995.
37. METTLIN, C.; MURPHY, G.P.; LEE, F.; y cols.: "Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project". J. Urol., 152: 1737, 1994.
38. PALKEN, M.; COBB, O.E.; SIMONS, C.E. y cols.: "Prostate cancer: comparison of digital rectal examination and transrectal ultrasound for screening". J. Urol., 145: 86, 1991.
39. HERRANZ AMO, F.; VERDU TARTAJO, F.; DÍEZ CORDERO, J.M. y cols.: "Incidencia de cáncer de próstata en los pacientes sintomáticos con tacto rectal no sospechoso y niveles de PSA mayores de 10 ng/ml". Actas Urol. Esp., 23: 316, 1999.
40. LUJAN GALÁN, M.; PÁEZ BORDA, A.; LLANES GONZÁLEZ, L.: "Rasgos diferenciales del cáncer de próstata procedente de un programa de detección precoz frente al detectado en una consulta de urología". Actas Urol. Esp., 24: 640, 2000.
41. DJAVAN, B.; ZLOTTA, A.R.; EKANE, S. y cols.: "Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield". Eur. Urol., 38: 218, 2000.
42. MOROTE, J.; LÓPEZ, M.; DE TORRES, I.M.: "Influencia de la neoplasia intraepitelial prostática en la concentración sérica de PSA y porcentaje de PSA libre". Actas Urol. Esp., 23: 342, 1999.
43. ROEHL, K.A.; ANTENOR, J.A.; CATALONA, W.J.: "Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng/ml range". J. Urol., 168: 922, 2002.
44. BABAIAN, R.J.; JOHNSTON, D.A.; NACCARATO. W. y cols.: "The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy". J. Urol., 165: 757, 2001.
45. SCHRODER, F.H.; VAN DER CRUIJSEN-KOETER, I.; DE KONING, H.J. y cols.: "Prostate cancer detection at low prostate specific antigen". J. Urol., 163: 806, 2000.
46. GÓMEZ DE VICENTE, J.M.; LUJÁN GALÁN, M.; PAEZ BORDA, A.: "Detección del cáncer de próstata en el rango de PSA entre 3 y 3,9 ng/ml". Actas Urol. Esp., 26: 271, 2002.
47. THOMPSON, I.M.; PAULER, D.K.; GOODMAN, P.J. y cols.: "Prevalence of prostate cancer among men with a Prostate-Specific Antigen level ≤4.0 ng per mililiter". N. Engl. J. Med., 350: 2239, 2004.